Ginkgo Bioworks Holdings (DNA) Depreciation & Amortization (CF) (2020 - 2026)

Ginkgo Bioworks Holdings (DNA) has reported Depreciation & Amortization (CF) for 7 consecutive years, with $12.3 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Depreciation & Amortization (CF) fell 19.24% year-over-year to $12.3 million; the trailing twelve-month figure through Jun 2026 stood at $52.9 million (down 15.82% YoY), and the FY2025 full-year result was $59.0 million, down 6.39% from the prior year.
• Depreciation & Amortization (CF) slipped to $12.3 million in Q2 2026 per DNA's latest filing, from $12.8 million in the prior quarter.
• Across five years, Depreciation & Amortization (CF) topped out at $21.1 million in Q3 2023 and bottomed at $8.9 million in Q3 2022.
• Historically, Depreciation & Amortization (CF) has averaged $14.4 million across 5 years, with a median of $14.5 million in 2025.
• The sharpest annual moves came in 2023 and 2024: Depreciation & Amortization (CF) soared 136.18% in 2023, then plunged 32.12% in 2024.
• Over 5 years, Depreciation & Amortization (CF) stood at $15.7 million in 2022, then retreated by 18.06% to $12.8 million in 2023, then increased by 21.93% to $15.7 million in 2024, then slipped by 12.71% to $13.7 million in 2025, then fell by 9.87% to $12.3 million in 2026.
• According to Business Quant data, Depreciation & Amortization (CF) over the past three periods registered $12.3 million, $12.8 million, and $13.7 million for Q2 2026, Q1 2026, and Q4 2025 respectively.